REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHgCapital Trust plc Regulatory News (HGT)

Share Price Information for HgCapital Trust plc (HGT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 496.00
Bid: 492.50
Ask: 498.00
Change: 2.50 (0.51%)
Spread: 5.50 (1.117%)
Open: 494.00
High: 496.00
Low: 492.00
Prev. Close: 493.50
HGT Live PriceLast checked at -
HgCapital is an Investment Trust

To provide shareholders with long-term capital appreciation in excess of the FTSE All Share Index by investing in unquoted companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison issues review on HG Capital Trust (HGT)

4 Aug 2023 07:15

RNS Number : 2073I
HgCapital Trust PLC
04 August 2023
 

London, UK, 4 August 2023

 

Edison issues review on HG Capital Trust (HGT)

HgCapital Trust (HGT) continues to operate against the backdrop of a tougher macroeconomic environment, muted M&A markets and higher interest rates. Nevertheless, it delivered a 12-month NAV TR to end-March 2023 of 10.3%, which supports its longer-term outperformance of listed PE peers and major public indices. While Hg (its investment manager) expects some pressure on sales to new customers across HGT's portfolio, it sees several other organic growth drivers, including cross- and up-sell. Last 12 month (LTM) revenue and EBITDA growth to end-March 2023 remained high across its top 20 holdings at 30% and 27%, respectively.

 

Despite the tougher external environment, SaaS companies are expected to continue generating healthy top-line growth and increasing profitability over the next two years, with current Refinitiv consensus implying revenue and EBITDA growth at c 10-15% pa. HGT is a quality play in the sector, underpinned by the defensive growth profile of its holdings, Hg's sector expertise, in-house value creation team and buy-and-build strategy. HGT has historically delivered revenue and EBITDA growth of 20-30% pa at a margin above 25% (FY22: 29%) across its top 20 holdings. Therefore, it fulfils the 'Rule of 40', which warrants a valuation premium versus the broader private IT sector. The shares now trade at a c 17% discount to end-March 2023 NAV.

Click here to view the full report.

 

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors. By focusing on the volume and quality of investors reached - across institutions, family offices, wealth managers and retail investors - Edison can create and gauge intent to purchase, even in the darkest pools of capital, and then make introductions via non-deal roadshows, events or virtual meetings.

Having been the first company in-market 17 years ago, Edison has more than 100 employees and covers every economic sector. Headquartered in London, Edison also has offices in New York, Sydney and Wellington.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

Milosz Papst +44 (0)20 3077 5720 investmenttrusts@edisongroup.com

Learn more at www.edisongroup.com and connect with Edison on: 

LinkedIn www.linkedin.com/company/edison-group-/

Twitter www.twitter.com/Edison_Inv_Res

YouTube www.youtube.com/edisonitv

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRADXLBBXVLXBBK
Date   Source Headline
14th Sep 20207:00 amRNSInterim Report and Accounts
21st Aug 20207:00 amRNSHg further invests in Visma
20th Aug 202011:00 amRNSHg further invests in Sovos
20th Aug 20207:00 amRNSSale of Citation Group
3rd Aug 20207:00 amRNSEvaluate Ltd secures additional investment from Hg
21st Jul 20205:44 pmRNSHolding(s) in Company
21st Jul 20209:39 amRNSDirectorate Change
9th Jul 202012:01 pmRNSEdison issues review on HgCapital Trust (HGT)
7th Jul 20208:00 amRNSHg invests in F24
30th Jun 20205:31 pmRNSTotal Voting Rights
25th Jun 20205:33 pmRNSIssue of Equity
22nd Jun 202012:47 pmRNSIssue of Equity
19th Jun 20204:38 pmRNSBlock listing six monthly return
15th Jun 20204:36 pmRNSPrice Monitoring Extension
4th Jun 20206:21 pmRNSDirector/PDMR Shareholding
4th Jun 20205:47 pmRNSDirector/PDMR Shareholding
4th Jun 202012:02 pmRNSPrice Monitoring Extension
28th May 20205:07 pmRNSIssue of Equity and Total Voting Rights
19th May 20202:25 pmRNSDirector/PDMR Shareholding
13th May 20207:00 amRNSAGM Results and Directorate Change
11th May 20207:00 amRNSQ1 Report to 31 March 2020
27th Apr 20205:36 pmRNSDisclosure of rights attached to equity shares
16th Apr 20207:00 amRNSDividend and AGM Update
9th Apr 20204:36 pmRNSPrice Monitoring Extension
24th Mar 20209:00 amRNSCOVID-19 Update
20th Mar 20204:42 pmRNSSecond Price Monitoring Extn
20th Mar 20204:35 pmRNSPrice Monitoring Extension
9th Mar 20207:00 amRNSFull-Year Report
9th Mar 20207:00 amRNSAnnual Financial Report
7th Feb 20207:00 amRNSHg invests in smartTrade Technologies
23rd Jan 20209:19 amRNSHg invests in Intelerad Medical Systems
2nd Jan 20207:00 amRNSTotal Voting Rights
2nd Jan 20207:00 amRNSIssue of Equity
30th Dec 20197:00 amRNSIssue of Equity
23rd Dec 20197:00 amRNSHg Saturn Fund acquires P&I from Permira funds
20th Dec 20195:57 pmRNSBlock listing six monthly return
18th Dec 20197:00 amRNSIssue of Equity
17th Dec 20197:00 amRNSIssue of Equity
16th Dec 20197:00 amRNSIssue of Equity
3rd Dec 20197:00 amRNSIssue of Equity
29th Nov 20191:22 pmRNSTotal Voting Rights
29th Nov 201911:39 amRNSHolding(s) in Company
28th Nov 20197:00 amRNSIssue of Equity
18th Nov 20191:06 pmRNSHolding(s) in Company
14th Nov 20194:57 pmRNSIssue of Equity
11th Nov 20195:38 pmRNSDirector/PDMR Shareholding
11th Nov 20197:00 amRNSQ3 Report to 30 September 2019
30th Oct 20195:59 pmRNSDirector/PDMR Shareholding
30th Oct 20194:47 pmRNSDirector/PDMR Shareholding
22nd Oct 20195:49 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.